Epidemiology and Impact of Coinfections Acquired fromIxodesTicks
- 1 December 2002
- journal article
- review article
- Published by Mary Ann Liebert Inc in Vector-Borne and Zoonotic Diseases
- Vol. 2 (4) , 265-273
- https://doi.org/10.1089/153036602321653851
Abstract
Ixodes scapularis and other ticks in the Ixodes ricinus complex may transmit multiple pathogens, but research on coinfections has been limited. Coinfections occur with varying frequency in ticks, but single infections are more common than dual infections. The proportion of I. scapularis or I. ricinus ticks coinfected with both Borrelia burgdorferi sensu lato and Anaplasma phagocytophila is generally low, ranging from A. phagocytophila are present in some tick populations, and they may affect the risk of coinfection or clinical illness. The proportion of Ixodes ticks coinfected with B. burgdorferi and Babesia microti has ranged from 2% in New Jersey to 19% on Nantucket Island, Massachusetts. In humans, cross-sectional seroprevalence studies have found markers of dual infection in 9–26% of patients with a tick-borne infection, but such studies often fail to distinguish simultaneous coinfection from sequential infections. Several studies have prospectively assessed the occurrence of acute coinfection. Among patients with a confirmed tick-borne infection, coinfection rates as high as 39% have been reported. The most commonly recognized coinfection in most of the eastern United States is Lyme borreliosis (LB) and babesiosis, accounting for ~80% of coinfections. LB and human granulocytic ehrlichiosis coinfections are less common, occurring in 3–15% of patients with a tick-borne infection in Connecticut or Wisconsin. Studies of clinical outcomes suggest that patients with acute Babesia coinfection have more severe symptoms and a longer duration of illness than patients with LB alone, but the risk of spirochete dissemination is similar. Coinfections can modify the immune response and alter the severity of arthritis in animal models. Future coinfection research should focus on long-term clinical outcomes, the role of genetic variants, immunologic effects, and the potential role of Bartonella species as tick-borne pathogens.Keywords
This publication has 51 references indexed in Scilit:
- Increased Arthritis Severity in Mice Coinfected withBorrelia burgdorferiandBabesia microtiThe Journal of Infectious Diseases, 2002
- Disease‐Specific Diagnosis of Coinfecting Tickborne Zoonoses: Babesiosis, Human Granulocytic Ehrlichiosis, and Lyme DiseaseClinical Infectious Diseases, 2002
- Outcomes of Treated Human Granulocytic Ehrlichiosis CasesEmerging Infectious Diseases, 2002
- Population‐Based Incidence of Human Granulocytic Ehrlichiosis in Northwestern Wisconsin, 1997–1999The Journal of Infectious Diseases, 2001
- Tickborne Infections as a Cause of Nonspecific Febrile Illness in WisconsinClinical Infectious Diseases, 2001
- Coexposure to Borrelia burgdorferi and Babesia microti Does Not Worsen the Long-Term Outcome of Lyme DiseaseClinical Infectious Diseases, 2000
- Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL‐2 and IFNγ production and promotes an IL‐4 response in C3H/HeJ miceParasite Immunology, 2000
- Clinical and Epidemiological Features of Early Lyme Disease and Human Granulocytic Ehrlichiosis in WisconsinClinical Infectious Diseases, 1999
- Serological Evidence of Human Granulocytic Ehrlichiosis in SwitzerlandEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Genetic Heterogeneity of Borrelia burgdorferi in the United StatesThe Journal of Infectious Diseases, 1997